Overview
PEPS ranks this pair inside the Top 300 market-cap universe. That means BDX and Injective are liquid enough for an indexable comparison, with metrics refreshed on the hourly coin pipeline.
Quick winners
Full comparison
| Metric | BDX | INJ |
|---|---|---|
| Price | $1,861.76 | $5.02 |
| Market Cap | $645.98M | $490.41M |
| FDV | — | — |
| Volume 24h | $13.24M | $3.09M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 87.00 | 98.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.50% | +5.78% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | BDX | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -1.20% | +2.14% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | BDX | INJ |
|---|---|---|
| RSI | 54.31 | 53.92 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 66.45 | 0.29 |
| ADX | 20.44 | 12.69 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 60.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across BDX and Injective, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | BDX | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
BDX
Injective
Pros and cons
Pros of BDX
- Higher ranking for BDX can translate into tighter spreads on major venues.
- BDX has an established coin page footprint on PEPS for continuous monitoring.
- Market-cap scale on BDX may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for BDX can surface clearer module agreement during trend phases.
Cons of BDX
- Large-cap status for BDX can mean slower percentage upside versus high-beta alternatives.
- When dominance narratives fade, BDX can lag hotter rotation names.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
Pros of Injective
- Diversifying versus BDX with Injective can change portfolio factor exposure.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
Cons of Injective
- Trend failures on Injective often travel faster than on more established assets.
- Smaller book depth versus large caps can increase slippage for Injective.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. BDX and Injective can alternate leadership as macro liquidity and narrative rotate.
AI summary
This AI-assisted summary starts from live PEPS fields. BDX holds market-cap $645.98M and rank #87; Injective shows $490.41M and #98. Where liquidity and flow matter, watch BDX. Where durability matters, watch BDX. AI composite scores (58.10/48.70) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, BDX or Injective?
“Better” depends on horizon and risk. BDX leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, BDX or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both BDX and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. BDX currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.